The study of efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma(HCC): Multicenter analysis.
Latest Information Update: 02 Feb 2021
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 02 Feb 2021 New trial record